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Background: Earlier, proteomic profiling of a Serous Ovarian Carcinoma (SeOvCa) progression model in our lab
had identified significantly enriched expression of three double-strand break (DSB) -repair proteins viz. RAD50,
NPM1, and XRCC5 in transformed cells over pre-transformed, non-tumorigenic cells. Analysis of the functional
relevance of enhanced levels of these proteins was explored in transformed ovarian cancer cells.
Methods: Expression profiling, validation and quantitation of the DSB-repair proteins at the transcriptional and
protein levels were carried out. Further analyses included identification of their localization, distribution and
modulation on exposure to Estradiol (E2) and cisplatin. Effects on silencing of each of these under conditions of
genomic-stress were studied with respect to apoptosis, alterations in nuclear morphology and DNA fragmentation;
besides profiling known mitotic and spindle check-point markers in DSB-repair.
Results: We identified that levels of these DSB-repair proteins were elevated not only in our model, but generally
in cancer and are specifically triggered in response to genotoxic stress. Silencing of their expression led to aberrant
DSB repair and consequently, p53/p21 mediated apoptosis. Further compromised functionality generated
genomic instability.
Conclusions: Present study elucidates a functional relevance of NPM1, RAD50 and XRCC5 DSB-repair proteins
towards ensuring survival and evasion of apoptosis during ovarian transformation, emphasizing their contribution
and association with disease progression in high-grade SeOvCa.
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Expression of numerous markers associated with DNA
damage signaling and repair pathways have been reported
in malignant cells [1]. It has also been suggested that such
proteins are expressed in response to several genotoxic
therapies including radiation and chemotherapeutic
drugs [2]. DNA double-strand break (DSB) repair, more
specifically homologous recombination (HR) mediated
repair pathway is reported to be frequently disrupted in
solid high-grade serous ovarian adenocarcinoma (SeOvCa)
tumors [3]. Overexpression of such DSB-repair associated
proteins is assumed to be associated with endogenous
replication stress and high frequency of DNA breaks in* Correspondence: sabapat@nccs.res.in
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distribution, and reproduction in any mediumtransformed cells [4,5], though functional relevance of
these markers remained largely uncharacterized during
the disease progression.
The basis of the current study is protein expression
profiling of SeOvCa progression model that was carried
out earlier and identified differential protein patterns
[6]. This protein profiling study was carried out using
an in vitro model of SeOvCa progression established
earlier in our lab [6,7]. In brief, several single cell
clones were isolated from the malignant ascites of a
grade IV SeOvCa patient. During subsequent culture,
nineteen of these clones underwent spontaneous im-
mortalization. One of these immortal clones viz. A4
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proliferating clone that exhibited tumorigenic and
metastatic capabilities in in vitro assays. This constitutes
the SeOvCa progression model system, wherein early
immortal A4 cells with non-tumorigenic potential were
termed as pre-transformed or A4-P, and transformed
A4-P derived tumorigenic and metastatic cells were
termed as A4-T (Additional file 1). With distinct cellu-
lar phenotype, such isogenic cellular system provided a
suitable progression model of two functionally discrete
cell types derived from a single clone. Protein profiling
of the progression model led to derivation of two groups
based on their qualitative and differential expression
patterns. Group I comprised of proteins, qualitatively
expressed in either A4-P or A4-T (termed as EEx and
LEx proteins based on their identification in Early and
Late passage A4 cells respectively), while Group II com-
prised of proteins expressed at quantitatively different
levels in each cell types (threshold = > 2, fold change).
Categorization of proteins into functional networks
provided a clear insight of cellular functionality and major
pathways regulating ovarian cell transformation.
Functional annotation of the 34 LEx proteins revealed
an association of diverse cellular processes including
resistance to apoptosis, energy metabolism, cell prolif-
eration, angiogenesis and invasion and metastases. Broadly
these represent some of the classical hallmarks of cancer
[8]. One of the progression-associated function was that
of DSB-repair in which, three proteins viz. RAD50, NPM1
& XRCC5 were identified as being highly enriched in
transformed cells. Around 50% of high grade SeOvCa
tumors exhibit aberrant DSB-repair functions and high
prevalence of mutations in DSB-repair genes [3]. In ex-
ploring the functional relevance associated with disease
progression, we focused on these three LEx proteins of
DSB-repair pathways. NPM1 has been suggested to
involved in the process of DNA repair in UV irradiated
cells [9] while, loss of NPM1 is found to constitutively
activate DNA damage response with increased levels of
histone H2AX phosphorylation [10]. NPM1 has been
recently identified to be recruited by ubiquitin conju-
gates downstream of RNF8 and RNF168 in HR pathway
[11]. RAD50 as a key component of MRN (MRE11,
RAD50 & NBS1) complex participates in both DSB re-
pair pathways of HR and non-homologous end-joining
(NHEJ), while XRCC5 is one of the key protein involved
in NHEJ repair [12-15].
On this background, to elucidate their contribution
to disease progression, we characterized the functional
involvement of NPM1, RAD50 and XRRC5 DSB-repair
proteins in ovarian cancer. Our study demonstrates an
approach of transformed cells towards combating DSB-
repair, impairment of which leads to apoptosis and gen-
omic instability.Methods
Cell culture, treatments and transfections
Derivation of the A4 progression model of pre-trans-
formed and transformed SeOvCa cells (A4-P and A4-T
cells) is described earlier [7,16]. A4-P cells (between pas-
sage numbers 15–17) and A4-T cells (between passage
numbers 37–38) were used in the study and cultured
stringently to avoid the risk of cross-contamination.
The A4-T cells were treated with estradiol (E2; 10 nM)
for 48 h and expression analysis of c-Myc, NPM1 and
RAD50 was performed. The siRNA pools of negative
control, NPM1, RAD50 and XRCC5 (MISSION siRNA;
Sigma Aldrich Inc.) were used for generating transient
knockdown cells. The A4-T cells were treated with 4 μM
cisplatin (Sigma Aldrich Inc.) for 24 h, 48 h time-points
and were subsequently used for expression analysis
and validation studies. In siRNA transfections, 10 nmol
siRNA duplexes were transfected into A4-T cells with
Lipofectamine RNAiMax (Invitrogen) according to the
manufacturer’s instructions, and cells were analyzed
for expression validation after 48 h of transfection. To
induce DNA damage and to examine H2AX-γ and NPM1
translocalization, A4-T cells 24 h after transfection
were treated with 4 μM cisplatin for 24 h before im-
munofluorescence analysis. The 4 μM cisplatin treatment
for 48 h post 24 h transfection was given to validate
protein expression levels of ATM, pATR(Str428), RAD50,
NPM1, XRCC5, p53, p21, CDK1, Cyclin D1, Bcl-2 and
β-actin.
Semi-quantitative reverse transcription-PCR
Trizol™ reagent (Invitrogen, USA) was used to extract
total RNA from cells as per manufacturer’s guidelines
[17]. Semi-quantitative reverse transcription-PCR was per-
formed under standard conditions as described earlier
[18] and amplified products were resolved on a 1.5%
Agarose gel; β-actin was used as internal control. Gel
was run and captured under gel documentation system
(Syngene; Cambridge, UK).
Antibodies, immunoblotting and quantitative analysis
Immunoblotting (IB) was performed as described earlier
[18]. Primary antibodies were used at following concent-
rations for IB and IF (immunofluorescence) applications;
anti-NPM1 (Sigma #WH0004869M1), 1:4000(IB), 1:150
(IF); anti-RAD50 (Sigma #R1653), 1:1000(IB), 1:100(IF);
anti-XRCC5 (Ku86, B-1) (Santa Cruz # sc-5280), 1:2000
(IB), 1:100(IF); anti-c-Myc (Origene # TA100010), 1:1000;
anti-Gamma H2AX (phospho Ser139) (Abcan #ab-11174),
1:2000(IB), 1:100(IF); anti-ATM (H-248) (Santa Cruz #sc-
7230), 1:1000; anti-phospho-ATR(Ser428) (Cell Signaling
#2853), 1:1000(IB); anti-p53 (DO-1) (Santa Cruz # sc-126),
1:1000(IB), 1:100(IF); anti-p21 (BD #556430), 1:1500; anti-
Bcl-2 [8] (Santa Cruz # sc-130308), anti-Cyclin D1 (BD
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1:1000; anti-α-tubulin (Sigma #T5168), 1:5000(IF); ant-
γ-tubulin (Sigma #5192), 1:1000(IF); anti-MAD2 (E-17)
(Santa Cruz # sc-31790), 1:100(IF), and anti-BUBR1
(N-20) (Santa Cruz # sc-16193), 1:100(IF). Probing with
an anti-β-actin antibody (Clone AC-15) (Sigma # A1978),
1:10,000(IB); served as a loading control. Secondary an-
tibodies linked with horseradish peroxidase (HRP) were
used as follows: anti-rabbit (1:1500), anti-mouse (1: 1500)
procured from Amersham (Pharmacia Biotech, Little
Chalfont, UK). Immunoblots were scanned and densi-
tometry for quantitative analysis was performed using
a Syngene Gene Genius™ Gel Documentation System
(Syngene; Scientific Laboratory Supplies; #www.
syngene.com). Protein expression values normalized
with β-actin were represented as relative expression
in percentage.Cell cycle and apoptosis assay
Cell cycle analysis of transfected cells was performed with
PI (Propidium-Iodide) staining using standard procedure
[19]. Sample acquisition and data analysis was per-
formed on FACSCalibur (Becton Dickinson, San Diego,
CA, http://www.bdbiosciences.com) using ModFit ana-
lytical software. Annexin V–FITC apoptosis assay was
performed as described earlier [18] and acquisitions
were made on FACSCanto II (Becton Dickinson); DiVa
software (Becton Dickinson) was used for data analysis.Immunofluorescence staining and In-situ fluorescein
cell-death detection (TUNEL) assay
Control siRNA, siNPM1, siRAD50 and siXRCC5 trans-
fected A4-T cells were grown on cover slips for 24 h
followed by treatment with cisplatin and E2 for 24-48 h
wherever indicated. After treatment, media was decanted
and wells washed with 1X PBS buffer. Cells were fixed
with 4% paraformaldehyde and were kept for 10 min on
ice. Immunofluorescence staining was performed as
described earlier [19] using NPM1, RAD50, XRCC5,
H2AX-γ and p53 antibodies; Hoechst was used for
nuclear staining. Images were acquired and analyzed
on confocal microscope (Carl Zeiss, Jena, Germany).
Quantification of intensity of p53 nuclear foci was
carried by measuring the expression intensity across
nuclei dimension on Leica LAS_AF analysis platform.
Intensity of p53 foci was represented on y-axis, while
distance or length of nuclei is shown at x-axis. TUNEL
Assay was performed as described earlier [18]. Cells
with labeling solutions (Roche) were taken as negative
control. Cells were washed thrice and stained with
Hoechst for nuclear staining. Stained samples were
acquired and analyzed on confocal microscope (Leica,
Germany).Giemsa staining
Control, NPM1, RAD50 and XRCC5 siRNA transfected
A4-T cells were grown in 24 well plate and treated with
cisplatin (4 μM) and E2 (10 nM) for next 48 h. Upon
harvesting, cells were washed twice with chilled 1X
phosphate buffer saline (PBS) and then fixed with ice-
cold absolute methanol for 20 min at 4°C. Cells were
rinsed once with PBS and incubated with Giemsa stain
for 30 min at RT. Further, cells were washed twice
with 1X PBS and analyzed under Olympus microscopy
(Olympus Co., Tokyo, Japan) at 40X magnification.
Statistical analysis
All experiments were carried out in triplicate; data are
expressed as mean ± SEM of three independent expe-
riments. The significance of difference in the mean
values was determined using two-tailed Student's t test;
wherein p < 0.05 considered significant. ANOVA test
was performed to compare protein expression between
the groups at a significance level of < 0.05. Student-
Bonferroni test was used to evaluate sub-comparisons
to error rate.
Results
Transformation-associated DSB Repair proteins are
enriched in ovarian cancer
An earlier study on proteomic profiling of the SeOvCa
progression in our lab had categorized differentially
identified proteins into two groups, where Group I
comprised EEx and LEx sub-groups consisting 10 and
34 proteins respectively, while Group II comprised 31 and
48 differentially upregulated proteins identified in A4-P
and A4-T cells respectively (Figure 1A). Identification
of 34 proteins in transformed A4 cells (LEx proteins in
Group I) led to the derivation of 14 diverse cellular pro-
cesses based on literature based functional annotation
(Additional file 2). Towards understanding the functional
relevance of LEx proteins, we focused on NPM1 that
participates in six of the above pathways. Very limited
information is available on its role in DSB repair, wherein
two other proteins viz. RAD50 and XRCC5 were also
identified as being LEx proteins. We thus decided to
explore the functional relevance of these proteins in
the transformed cells since aberrations in this pathway
contribute to genetic (in)stability in several malignancies.
As an initial step, we profiled RAD50, NPM1 and XRCC5
protein expression, which confirmed their enriched levels
in the transformed or A4-T cells (Figure 1B), though much
lower levels can be detected in A4-P cells. This was more
striking for NPM1 than the other two proteins (Figure 1C).
Expression profiling in HPA (Human protein atlas) re-
vealed enrichment of these in ovarian cancer samples
and cell line, though lower levels in stromal and follicle
cells were also marked (Figure 1D). Expression levels of
Figure 1 Validation of NPM1, RAD50 and XRCC5 expression in ovarian cancer. A. Schematic demonstration showing proteomic profiling
of SeOvCa progression model which leads to derivation of two expression groups; Group I comprise qualitative expressions, while Group II
consist of differentially upregulated proteins. (Groups were further divided in two sub-groups of A4-P and A4-T cells). B. Representative
immunoblot validating qualitative expression of NPM1, RAD50 and XRCC5 proteins in A4-T cells over A4-P cells; numbers indicate mean
fold-change values. C. Quantitation of NPM1, RAD50 and XRCC5 proteins expression levels. D. Expression levels of NPM1, RAD50 and XRCC5
proteins in ovarian cancer samples and cell line (i.e. EF0-21) analyses in HPA database (www.proteinatlas.org). Expression levels of NPM1,
RAD50 and XRCC5 proteins were analyzed in 11, 9 and 6 tumors respectively, derived from high grade serous adenocarcinoma patients
(HPA accession nos. ENSG00000181163, ENSG00000113522 and ENSG00000079246 respectively). The red, yellow and light brown colour boxes
showing strong, moderate and weak expression (antibody staining intensity) of these targets in the HPA database, while white box represents
negative expression. The length of boxes in ovarian cancer indicates overall cancer tissue staining statistics in percentage. Data is indicated
as mean ± SE of triplicate experiments. *p <0.05,**p <0.01.
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cancer and leukemic cell lines expression data available
in the HPA database. All three proteins were enriched
in various cancer cell lines, while levels of NPM1 and
XRCC5 were more significantly elevated in leukemic
cell lines (Additional file 3A,B,C).
In DSB-repair pathway, RAD50 serves as a key com-
ponent of MRN complex which is regulated by ATM
kinase signaling and bilaterally involved in DSB repair
and thereby regulates both HR and NHEJ pathways;
while NPM1 and XRCC5 are associated with HR and
NHEJ pathways respectively (Figure 2A) [9-15]. c-Myc
as being a transcription factor, is known to modulate
process of cellular transformation. Our earlier studies
suggest a role for c-myc in transformation in HGSC
[20]. Towards examining its role in SeOvCa progression
model, total identified proteins in A4-T cells were matched
with online c-Myc portal (www.myc-cancer-gene.org).
This identified 3 and 8 proteins as transcriptional targets
of c-Myc in Group I and II respectively (Additional file
4A). Most of these targets were found to be associated
with protein metabolism, cell redox reactions and DSB-
repair pathways (Additional file 4B). NPM1 and RAD50
were thus suggested to be transcriptional targets of c-
Myc [21]; while c-Myc itself is known to be regulated
at the transcriptional level by estrogen through the
estrogen receptor [22,23]. We have earlier reportedER-α expression in A4 cells [20]; thus, we tested and
validated the functionality of such possible cross-talk
by treatment of A4-T cells with 10nM E2 that consecu-
tively led to elevated c-Myc levels (Figure 2B – upper
panel; Additional file 4C) followed by enhanced NPM1
expression (Figure 2B – lower panel) suggesting a regu-
latory association of c-Myc in transcriptional regulation
of NPM1. However, such a correlation with RAD50 ex-
pression could not be seen (Figure 2B – lower panel).
Transformation-associated DSB-repair proteins are
responsive to genotoxic stress
Towards investigating the relevance of DSB-repair on
genotoxic stress, we induced DSB with 4 μM cisplatin-a
genotoxic agent known to form interstrand and intra-
strand adducts upon interaction with DNA [24]. The
expression of DSB marker i.e. H2AX-γ was significantly
upregulated along with the levels of all three DSB re-
pair molecules, though it was much marked for RAD50
and XRCC5 (Figure 2C, 2D). An interesting feature ob-
served was that while the levels of NPM1 were drastic-
ally increased on transformation, they were marginally
altered on subsequent exposure to genotoxic stress. On
profiling its localization at steady-state and under DSB
stress, NPM1 was seen to be exported from the nucleolus
to the nucleoplasm within 24 h of cisplatin treatment
(Figure 2E). The cells treated with cisplatin showed surface
Figure 2 Status of RAD50, NPM1 and XRCC5 in DSB-repair pathway and modulation of their expression on E2 and cisplatin treatment.
A. Schematic diagram showing designations of RAD50, NPM1 and XRCC5 in HR and NHEJ pathways of DSB-repair. B. Representative immunoblot
showing elevated expression of c-Myc on 10nM E2 treatment (upper panel); fold-change expression of c-Myc, NPM1 and RAD50 mRNA and
protein (lower panel). C. Representative immunoblots of H2AX-γ, NPM1, RAD50 and XRCC5 on 4 μM Cisplatin treatment; numbers indicate mean
fold-change values. D. Immunofluorescence staining indicating NPM1, RAD50 and XRCC5 expression on 4 μM Cisplatin treatment in comparison
to untreated control A4-T cells; Scale bar 25 μm. E. Immunofluorescence staining showing translocation of NPM1 from nucleolus to nucleoplasm
within 24 h upon 4 μM cisplatin treatment in A4-T cells in comparison to untreated cells. Scale bar 8 μm. Data shown as mean ± SE of triplicate
experiments. *p <0.05,**p <0.01.
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untreated control that indicated onset of cellular stress
and apoptosis in a significant cellular fraction (Additional
file 4D,E,F). The translocation of NPM1 from the nu-
cleolus to the nucleoplasm may suggest activation and
a shift to perform its functional role in DSB-repair.
Impaired DSB-repair and genotoxic stress leads to
cellular apoptosis
In order to elucidate the functional role of these proteins
in DSB repair, we silenced each of these three key mole-
cules in A4-T cells followed by 4 μM cisplatin treatment.
A significantly higher XRCC5 levels in NPM1 silenced
cells and vice-versa, was observed (Additional file 5A,
B). Cisplatin treatment led to an increment in H2AX-γ,
RAD50, NPM1, XRCC5 and p53 in all treated sets.
Numbers of p53 nuclear foci in DSB-repair protein
silenced cells observed higher in comparison to the
siRNA control cells (Figure 3A). Silencing of RAD50
under genotoxic stress increased the number of p53
foci in treated cells that may correlate with functionally
compromised MRN complex; though this increment in
the p53 foci in siNPM1 cells appeared higher in com-
parison to the siRAD50 silenced cells. Increased p53
foci in NPM1 silenced cells suggest defective HR path-
way and also loss of NPM1 regulation of p53 activity
[25], while those in XRCC5 silenced cells may predict
fate of cells with impaired NHEJ pathway. Further, highfrequency of p53 nuclear foci in siNPM1 and siXRCC5
cells, and a relatively lower one in siRAD50 cells was
observed (Figure 3B, Additional file 5C).
NPM1 silencing led to significantly elevated XRCC5
levels in these compromised HR DSB-repair cells; like-
wise, NHEJ compromised cells on XRCC5 silencing ex-
hibited elevated NPM1 levels (Additional file 5B). Such
enhanced expression of XRCC5 and NPM1 across al-
ternatively silenced cells indicated prompt activation of
respective NHEJ or HR pathways in these impaired cells.
In sensitive cells, cisplatin treatment is known to regulate
p53 stability and transcriptional activity upon activation
of ATM and ATR kinase, while the transient sub-nuclear
redistribution of NPM1 may suggest its activation through
a direct interaction with p53 independently of ARF
[10,25]. The suggested regulatory cross-talk with p53
prompted us to further profile the protein expression
of some key p53-regulatory network molecules activated
by ATR phosphorylation (Ser428) or ATM and H2AX-γ
expression in cisplatin treated cells (Figure 3B, Additional
file 5D). The activated p53 with its down-stream modula-
tor p21 suggested lower Bcl-2 levels in NPM1 silenced
cells in comparison to control siRNA transfected cells,
though p21 levels appear unaltered throughout the set
that may reflect transient stability or a sort half-life of
p21 protein. A slightly higher Bcl-2 level in siXRCC5
cells in comparison to siNPM1 and siRAD50 cells may
suggest stimulation of the error-free DSB-repair mediated
Figure 3 DSB response triggers p53 signaling under genomic stress. A. Immunofluorescence staining showing expression of RAD50,
NPM1, XRCC5, H2AX-γ and p53 at steady state and 4 μM cisplatin treated control siRNA, siRAD50, siNPM1 and siXRCC5 A4-T cells. B.
Quantitation of ATM, H2AX-γ, p53, p21, CDK1, Cyclin D1 and Bcl-2 protein expressions in untreated and cisplatin treated A4-T, control siRNA,
siRAD50, siNPM1 and siXRCC5 A4-T cells. C. In-Situ fluorescein cell death (TUNEL) analysis showing nuclear fragmentation (red foci) in
untreated and cisplatin treated control siRNA, siRAD50, siNPM1 and siXRCC5 A4-T cells (Red color- pseudo color instead of green). D.
Quantitative analysis of TUNEL assay showing percentage apoptotic populations in complete set of untreated and cisplatin treated A4-T,
control siRNA, siRAD50, siNPM1 and siXRCC5 cells. Scale bar is 12 μm. Data shown as mean ± SE of triplicate experiments. *p <0.05; **p <0.01;
***p <0.001.
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from p53-mediated apoptosis. Lower levels of Cyclin D1
and Cdk1 in DSB-repair protein silenced cells in com-
parison to control siRNA cells exhibits p53/p21 mediated
control over cell cycle progression in RAD50, NPM1
and XRCC5 silenced cells, though individual Cdk-1
levels in siXRCC5 cells were found significantly lower.
We observed incidences of nuclear fragmentation in
RAD50 and NPM1 silenced cells in comparison to con-
trol siRNA transfected cells (Additional file 5E). The
consequence of these incidences i.e. cellular apoptosis
were quantified through TUNEL assay in the complete
treatment set (Figure 3C) wherein, higher levels of nu-
clear fragmentation in the RAD50 and NPM1 silencedcells in comparison to control siRNA transfected cells
corroborate with the above results (Figure 3D).
Compromised HR & NHEJ-repair pathways result in
genomic instability in transformed cells
The above results suggest that cells with compromised
DSB-repair on being subjected to stress are frequently
eliminated through p53/p21 led apoptosis at a high fre-
quency. We further probed the effects of defective HR &
NHEJ pathways on mitosis and genomic integrity in the
cells surviving under the same stress through a detailed
screening of nuclear morphology. A close investigation
of nuclear morphology in RAD50, NPM1 and XRCC5
silenced cells showed frequent incidences of improper
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cleated cells and abnormal mitotic figures (Figure 4A;
Additional file 6A). This consistently revealed 7–9 fold
higher nuclear irregularities of multi-nucleation, abnor-
mal and reduced mitoses in compromised DSB-repair
cells in comparison to the siRNA control (Figure 4A).
A detailed analysis of nuclear morphology at steady
state and mitosis evidently revealed occurrence of
nuclear condensation and faulty mitotic progression in
RAD50, NPM1 and XRCC5 silenced cells (Additional
file 6B).
We further analyzed mitotic nuclei to demonstrate the
probability of aberrant spindle formation in DSB-repair
deficient cells. The α-tubulin and γ-tubulin staining of
mitotic nuclei revealed 5–9 fold aberrant mitotic-spindle
formation and higher numbers (>2) of centrosomes in
DSB-repair deficient cells (Figure 4B). Cyclin E-Cdk2
mediated phosphorylation of NPM1 has been suggested
to dissociate its binding from centrosomes at the G1-
phase of the cell cycle and permit centrosome duplica-
tion prior to cell division [26]. NPM1 silencing thereby
could lead to unrestricted centrosome duplication andFigure 4 Ablation of RAD50, NPM1 and XRCC5 lead to genomic insta
A. Representative Images of control siRNA, siNPM1, siRAD50 and XRCC5 A4
stained (lower) nuclei respectively. Marked arrow indicating incidences of a
the siRAD50, siNPM1 and siXRCC5 cells respectively, while in control siRNA
50 μm scale bar. Representative graphs indicating frequencies of mitosis an
siXRCC5 cells. B. Representative images of cells stained for α- and γ- tubulin
numbers and position of centrosomes during mitosis in control and siRAD
frequencies of aberrant spindle formation and cells with more than 2 centr
right. C. Graphical representation of flow cytometry based resolution of cel
indicative of control and siRAD50, siNPM1 and siXRCC5 cells through PI sta
*p <0.05; **p <0.01.impaired cell division followed by multinucleation. On
the other hand, RAD50 and XRCC5 silencing led to
irregular chromosomal segregation generating abnormal
mitotic figures. Such association of mitotic irregularities
with impaired DSB repair led us to examine genomic
content and ploidy levels in the silenced cells under
stress. While the former was not significantly altered,
the incidence of aneuploidy was enhanced 5–7 fold
times in cells with compromised DSB-repair in com-
parison to the transfected siRNA controls (Figure 4C).
Occurrence of mitotic irregularities and analyses of
genomic content in RAD50, NPM1 and XRCC5 silenced
cells demonstrated gain of genomic instability. Further,
MAD2 and BUBR1 levels (upregulations of which are
known to be associated with genomic instability) were
studied under genotoxic-stress (Additional file 6C). Ex-
pressions of MAD2 were found higher in RAD50 and
NPM1 silenced cells, while BUBR1 levels were slight
high in RAD50 silenced cells. Elevated expression of
MAD2 in these silenced cells may suggest progression
of genomic instability. Together, the data identifies
defective DSB-repair driven genomic instability (GI) thatbility and facilitate multinucleated cells and mitotic irregularities.
-T cells - panels indicate Giemsa (top), Hoechst (middle) and α-tubulin
bnormal mitotic figures, multi-nucleation and mitotic irregularities in
transfected cells it is denoting normal mitosis; 40X magnification;
d abnormal mitotic figures in control and siRAD50, siNPM1 and
expression indicating existence of abnormal spindles as well as
50, siNPM1 and siXRCC5 cells; representative graphs indicating
osomes in control and siRAD50, siNPM1 and siXRCC5 cells on the
l cycle phases and aneuploid genomic content associated with
ining. Data shown as mean ± SE of triplicate experiments.
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under genomic-stress.Discussion
In the present study, we investigated the functional rele-
vance of RAD50, NPM1 and XRCC5 in HR and NHEJ
pathways and explored their vital role in the process of
DSB-repair and evasion of apoptosis (Figure 5). Silencing
of the molecular expression of these key proteins leads
to aberrant functioning of DSB-repair pathways. It has
been shown earlier that loss of NPM1 expression could
elevate levels of H2AX phosphorylation on exposure to
UV radiation or DNA damage. In the HR DSB-repair
pathway, recruitment of phosphorylated NPM1 by ubi-
quitin conjugates downstream of RNF8 and RNF168
has been suggested [11]. Differentially upregulated levels
of two other DSB molecules viz. RUVBL1 and RUVBL2
was also affirmed in A4-T cells, wherein RUVBL1 is
known to be associated with c-Myc in promoting cellular
transformation [21]. In the present study, c-Myc mediated
modulation of NPM1 levels in an E2 dependent manner
was affirmed that indicates responsiveness of c-Myc to E2.Figure 5 Schematic model demonstrating functional involvement of N
ovarian cancer cells. Onset of environmental and therapeutic stress leads
phosphorylates H2AX histone variant. NPM1 and XRCC5 involved in HR and
alternatively activates NHEJ and HR pathways (red lines) towards maintainin
conditions, knock-down of RAD50, NPM1 and XRCC5 DSB-repair proteins le
apoptosis of DSB-repair impaired cells. On other hand, cells surviving with
irregularities and multi-polarity and aneuploidy, which conclusively facilitateTogether, this suggests the subsistence of several pathways
that cross-talk with each other.
Induction of H2AX-γ in response to genotoxic-stress
provided a suitable system to investigate the process of
DSB-repair in transformed cells. A nucleolar-nuclear
translocation of NPM1 on cisplatin induced genotoxic-
stress comprising a swift DSB-repair response in the
nucleoplasm was identified. High grade SeOvCa has
been suggested to harbor p53 mutation at advanced
stage [27], though it is found limited to 91-96% in serous
malignancies [3,28,29]. Activation of ATM dependent
p53/p21 signaling in compromised DSB repair cells leads
to downstream control over Bcl-2, Cdk-1 and Cyclin
D1 expression, such mechanistically coordinated process
affirms active p53 status in A4-T cells. Presence of stable
p21 levels, despite p53 activation justifies transient expres-
sion of p21 protein upon DNA damage. RAD50 silencing
apparently limits process of DSB repair down-stream of
the MRN complex; while activation of NHEJ or HR path-
ways in NPM1 or XRCC5 silenced cells interestingly
demonstrates alternative strategies for DSB-damage re-
pair (Figure 5). Higher frequency of apoptosis in NPM1
silenced cells in comparison to RAD50 and XRCC5PM1, RAD50 and XRCC5 in DSB-repair in the progression of
to the activation of ATM, which recruits MRN complex and
NHEJ pathways respectively. Knock-down of NPM1 and XRCC5 across
g DNA integrity and genomic stability. Under genomic stress
ad to the activation of p53/p21 signaling pathway resulted in onset of
impaired DSB-repair exhibit frequencies of reduced mitosis, mitotic
genomic instability in transformed cells.
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http://www.ovarianresearch.com/content/6/1/66silenced may justify consequence of cumulative shut-down
of several functions mediated by NPM1 [25,26]. Com-
promised DSB-repair process leads to the mitotic ir-
regularities and multinucleation; wherein unrestricted
centrosome duplication in the absence of NPM1 has
been reported [26]. Defective repair in NPM1 silenced
cells indicates probability of error-prone chromosomal
segregation of unrepaired DNA, resulted in generation
of aberrant and mutipolar mitotic spindles. Our findings
suggest enhanced expression of these three DSB repair
molecules is a crucial event during SeOvCa transform-
ation in order to maintain DNA integrity and genomic
stability (Figure 5). Conclusively, we demonstrated that
silencing of NPM1, RAD50 and XRCC5 in transformed
cells led to mitotic irregularities and aneuploidy. Elevated
levels of these DSB-markers in transformed cells are
essential to compensate the effects of high risk of DSB
events in transformed cells. In present study, analysis
of the functional relevance of these proteins of DSB-
repair extends current understanding of the process of
cellular transformation during progression of SeOvCa.Additional files
Additional file 1: Derivation of A4 clone and establishment of A4
SeOvCa progression model.
Additional file 2: Functional categorization of identified LEx
proteins. Table showing functional annotation based categorized of 34
LEx proteins to 14 cellular processes in transformed SeOvCa cells.
Additional file 3: NPM1, RAD50 and XRCC5 levels in HPA database.
Expression profiling of NPM1 (A), RAD50 (B) and XRCC5 (C) in cancer and
leukemic cell lines analyzed in the Human Protein Atlas (HPA) database
(www.proteinatlas.org). The red, yellow and light brown colour boxes
showing strong, moderate and weak expression (antibody staining
intensity) of these targets in the HPA database. The horizontal dotted line
represents mean of individual protein expression in various human cell
lines and leukemia samples, wherein dashed line represents range of
upper and lower expression values. Mean expression of the individual
proteins were represented in percentage with reference to the internal
immunostaining control.
Additional file 4: Identification of c-Myc targets in DSB-repair
functional group and E2 and cisplatin mediated expression
modulation. A. List of suggested c-Myc targets identified in qualitative
and differential upregulated groups of A4 transformed cells. B. Diagram
showing major cellular processes, categorized based on functional
annotation of identified c-Myc gene targets in A4 transformed cells. C.
Quantitation of c-Myc expression in untreated [NT] control and Estradiol
[E2] treated A4 transformed cells validated by immunoblotting;
representative graph shows c-Myc expressions relative to the β-actin
(represented in percentage post normalization with β-actin). D. Cisplatin
treatment induced cellular stress, where panel showing untreated (a) and
drug treated (b) A4 transformed cells. E. FACS profiles showing
comparative cisplatin mediated apoptosis in untreated and cisplatin
treated A4 transformed cells. F. Quantitation of apoptosis. Error bars
represent S.E. (n = 3). Data were shown as means ± SE of triplicate
experiments. *p <0.05 and **p <0.01.
Additional file 5: Evaluation of p53/p21 pathways activation in
NPM1, RAD50 and XRCC5 silenced cells under genetoxic stress.
A. Representative immunoblots of NPM1, RAD50 and XRCC5 in control
siRNA, siNPM1, siRAD50 and siXRCC5 silenced cells. B. Quantitation of
NPM1, RAD50 and XRCC5 protein expression in control siRNA andsiNPM1, siRAD50 & siXRCC5 transfected cells in cisplatin treated cells;
relative expression of these proteins were calculated in percentage upon
normalization with β-actin. C. Quantitative analysis of p53 foci in the
nucleus of cisplatin treated control siRNA and siNPM1, siRAD50 & siXRCC5
transfected cells. D. Representative immunoblots of ATM, pATR (Ser428),
H2AX-γ, RAD50, NPM1, XRCC5, p53, p21, CDK1, Cyclin D1, Bcl-2, Exo1 and
β-actin expressions in untreated and cisplatin treated A4-T, control siRNA,
siNPM1, siRAD50 and XRCC5 silenced A4 transformed cells. E.
Immunofluorescence staining showing nuclear fragmentation in NPM1
and RAD50 silenced cells on genotoxic stress. Scale bar is 37.5 μm.
Additional file 6: NPM1, RAD50 and XRCC5 deficiency led to
mitotic irregularities followed by genomic instability. A.
Immunofluorescence panel showing mitotic irregularities in RAD50,
XRCC5 silenced cells, wherein NPM1 silenced cells showing
multinucleation in comparison to the normal mitosis in control siRNA
(indicated by white arrow in control and RAD50, NPM1 and XRRC5
silenced cells); B. Representative Giemsa stained images of untreated
A4-T (i) and 4 μM cisplatin treated control siRNA, siNPM1, siRAD50 and
siXRCC5 A4-T cells (panels ii, iii, iv, v, vi respectively) in two sets; upper
images showing steady state while lower’s are mitotically active A4
transformed cells (black arrows in siNPM1, siRAD50 and siXRCC5 cells
indicating mitotic irregularities, while in cisplatin treated control cells and
control siRNA treated cells its showing condense nuclear configures).
Scale bar is 50 μm. Focus 40X. C. Immunofluorescence staining showing
expressions of MAD2 and BUBR1 in untreated and cisplatin treated A4-T,
control siRNA, RAD50, NPM1and XRCC5 silenced A4 transformed cells.
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